Safety, Feasibility, and Merits of Longitudinal Molecular Testing of Multiple Metastatic Sites to Inform mTNBC Patient Treatment in the Intensive Trial of Omics in Cancer.
Kimberly A BurtonElisabeth MahenEric Quentin KonnickSibel BlauMichael O DorschnerArturo B RamirezStephen C SchmechelChaozhong SongRahul ParulkarStephanie ParkerFrancis Mark SenecalColin C PritchardBrigham H MechamChristopher SzetoPatricia SpilmanJingchun ZhuVijayakrishna K GadiRoy RonenJackie StilwellEric KaldjianJanusz DutkowskiStephen Charles BenzShahrooz RabizadehPatrick Soon-ShiongC Anthony BlauPublished in: JCO precision oncology (2022)
Further exploration of this approach in patients with mTNBC is merited.